Ocular effects of cosmetic products and procedures

Ocular Surface

Volumn 4, Issue 2, 2006, Pages 94-102

  Coroneo, Minas T ^a   Franzco, Fracs ^a   Rosenberg, Marni L ^a   Cheung, Leanne M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Allergy; Blepharoplasty; Botulinum toxin; Colored contact lenses; Cosmetic products; Cosmetic surgery; Dry eye; Dyes; Mascara; Micropigmentation; Ophthalmic medications; Perfume; Toxicity

Indexed keywords

ADHESIVE AGENT; ALUMINUM SILICATE; ANTIGLAUCOMA AGENT; ANTIHISTAMINIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CANTHAXANTHIN; CORTICOSTEROID; COSMETIC; CYANOACRYLATE; DEXAMETHASONE; FLUOCINONIDE; HAIR DYE; HISTAMINE H1 RECEPTOR ANTAGONIST; IRON OXIDE; KETOCONAZOLE; LATANOPROST; NAPHAZOLINE; PERFUME; PHENYLEPHRINE; PROSTAGLANDIN DERIVATIVE; SHAMPOO; TETRYZOLINE; TRICHLOROACETIC ACID; UNINDEXED DRUG; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT;

ACCOMMODATION PARALYSIS; ALOPECIA; ALOPECIA AREATA; ARTICLE; BLEEDING DISORDER; BLEPHAROSPASM; BLURRED VISION; BODY PIERCING; CLOSED ANGLE GLAUCOMA; CONJUNCTIVA DISEASE; CONJUNCTIVAL HYPEREMIA; CONJUNCTIVITIS; CONTACT LENS; CORNEA DISEASE; DIPLOPIA; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DRY EYE; EPIPHORA; ESTHETIC SURGERY; EYE ALLERGY; EYE BURNING; EYE COLOR; EYE DISCOMFORT; EYE DISEASE; EYE IRRITATION; EYE TOXICITY; EYELASH; EYELID DISEASE; EYELID RECONSTRUCTION; FACE DISORDER; HEART ARRHYTHMIA; HUMAN; HYGIENE; INJECTION SITE STINGING; INTRAOCULAR PRESSURE; IRITIS; LASER SURGERY; MYDRIASIS; NONHUMAN; PTOSIS; PUNCTATE KERATITIS; RETINOPATHY; RISK ASSESSMENT; SCAR FORMATION; SEBORRHEIC DERMATITIS; SIDE EFFECT; SKIN BRUISING; SKIN DISEASE; SKIN PIGMENTATION; TATTOOING; TRICHIASIS; VISUAL DISORDER; PATIENT EDUCATION; REVIEW; RISK FACTOR;

COSMETIC TECHNIQUES; COSMETICS; EYE DISEASES; HUMANS; PATIENT EDUCATION; RISK FACTORS;

EID: 33646934135     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70031-9     Document Type: Article

References (124)

1. Etcoff N. Survival of the prettiest. The science of beauty. Doubleday, New York, 1999
2. Kloser PC. Ugly risks of beauty routines. Medscape Womens Health. 1996 Dec;1(12):3
3. Blumenfeld O, Nathansohn N, Yeshurun I, Ashkenazi I. [Eye cosmetics - the beauty and the beast] Harefuah 2005;144:357-62,381
4. Draelos ZD. Cosmetics and skin care products. A historical perspective. Dermatol Clin 2000 Oct;18:557-9
5. Grierson I. The eye book. Eyes and eye problems explained. Liverpool, Liverpool University Press, 2000
6. Craik J. The face of fashion: cultural studies in fashion. Routledge, 1993
7. Aucoin K. The art of makeup. New York, HarperCollins, 1994
8. Coroneo MT. Pterygium as an early indicator of ultraviolet insolation: a hypothesis. Br J Ophthalmol 1993;77:734-9
9. Tuohy KM. Contact lens. United State Patent Office 2,510,438, June 6, 1950
10. Bator KK, Salituro SM. Prosthetic soft contact lenses and you. Eye Contact Lens 2005;31:215-8
11. Scheman A. Adverse reactions to cosmetic ingredients: Dermatol Clin 2000;18:685-98
12. McGuinness R, Beaumont P. Gold dust retinopathy after the ingestion of canthaxanthine to produce skin-bronzing. Med J Aust 1985143:622-3
13. Harnois C, Samson J, Malenfant M, Rousseau A. Canthaxanthin retinopathy. Anatomic and functional reversibility. Arch Ophthalmol 1989:107:538-40
14. Sharkey JA. Idiopathic canthaxanthine retinopathy. Eur J Ophthalmol 1993;3:226-8
15. Gerner I, Liebsch M, Spielmann H. Assessment of the eye irritating properties of chemicals by applying alternatives to the Draize rabbit eye test: the use of QSARs and in vitro tests for the classification of eye irritation. Altern Lab Anim 2005;33:215-37
16. Gao Y, Kanengiser BE. Categorical evaluation of the ocular irritancy of cosmetic and consumer products by human ocular instillation procedures. J Cosmet Sci 2004;55:317-25
17. Ubels JL, Clousing DP. In vitro alternatives to the use of animals in ocular toxicology testing. Ocular Surface 2005;3:126-42
18. MacLean AL. Spray keratitis: a common epithelial keratitis from noncorrosive household sprays. Trans Am Acad Ophthalmol Otolaryngol 1967;71:330-40
19. Al-Abdulla NA, Kim MC. Aerosol keratopathy: a revised MacLean classification. Eur J Ophthalmol 2001;11:187-8
20. Satterfield D, Mannis MJ. Episodic bilateral corneal edema caused by hair groom gel. Am J Ophthalmol 1992;113:107-8
21. Fraunfelder FW, Fraunfelder FT, Goetsch RA. Adverse ocular effects from over-the-counter lice shampoo. Arch Ophthalmol 2003;121:1790-1
22. Savage HI, Edgington B, Appel J. Transient band-like keratopathy after treatment for seborrheic dermatitis. Cornea 2005;24:342-3
23. Mannis MJ, Miller RB, Krachmer JH. Contact thermal burns of the cornea from electric curling irons. Am J Ophthalmol 1984;98:336-9
24. Weiss JS. After-shave spray keratitis. Am J Ophthalmol 1988;106: 756-7
25. Engasser PG, Maibach HI. Cosmetics and skin care in dermatologic practice, in Freesberg IM, Eisen AZ, Wolff K (eds): Fitzpatrick's dermatology in general medicine. New York, Mc-Graw Hill, 2003, ed 6, pp 2369-79
26. Van Horn SD, Hovanesian JA, Maloney RK. Effect of volatile compounds on excimer laser power delivery. J Refract Surg 2002;18:524-8
27. Stephens TJ, McCulley JP, Tharpe M, et al: Localised eye area sensitivity syndrome. J Toxicol Cutaneous Ocul Toxicol 1989/ 1990;92:569-70
28. Mannis MJ, Sandler BJ. Keratitis induced by skin polish. Am J Ophthalmol 1988;106:104-5
29. Kaiserman I, Kaiserman N. Severe blepharoconjunctivitis induced by a peeling mask containing trichloroacetic acid. Ocul Immunol Inflamm 2005;13:257-9
30. Taneja S, Arora R, Yadava U. Fingernail trauma causing corneal laceration and intraocular cilia. Arch Ophthalmol 1998;116:530-1
31. Guin JD. Eyelid dermatitis from benzophenone used in nail enhancement. Contact Dermatitis 2000;43:308-9
32. Knight IJ. Mistaken eye drops and subsequent instillation of superglue. Eye 2001;15(Pt 5):663
33. Spencer TJ, Clark B. Self-inflicted superglue injuries. Med J Aust 2004;181:341
34. Grant WM, Schuman JS: Toxicology of the eye. Springfield, IL, Charles C Thomas, 1993, ed 4
35. Davis LJ, Paragina S, Kincaid MC. Mascara pigmentation of the bulbar conjunctiva associated with rigid gas permeable lens wear. OptomVis Sci 1992;69:66-71
36. Shields JA, Marr BP, Shields CL, Eagle RC Jr. Conjunctival mascaroma masquerading as melanoma. Cornea. 2005;24:496-7
37. (No authors listed). From the Centers for Disease Control. Pseudomonas aeruginosa corneal infection related to mascara applicator trauma - Georgia. JAMA 1990;263:1616
38. Wilson LA, Ahern DG. Pseudomonas-induced corneal ulcer associated with contaminated eye mascaras. Am J Ophthalmol 1977;84:112-9
39. Reid FR, Wood TO. Pseudomonas corneal ulcer. Arch Ophthalmol 1979;97:1640-1
40. Wilson LA, Julian AJ, Ahearn DG. The survival and growth of microorganisms in mascara during use. Am J Ophthalmol 1975;79: 596-601
41. Saxena M, Warshaw E, Ahmed DD. Eyelid allergic contact dermatitis to black iron oxide. Am J Contact Dermatitis 2001;12:38-9
42. Karlberg AT, Liden C, Ehrin E. Colophony in mascara as a cause of eyelid dermatitis. chemical analyses and patch testing. Acta Dermato-Venereologica 1991;71:445-7
43. Chowdhury MM. Allergic contact dermatitis from prime yellow carnauba wax and coathylene in mascara. Contact Dermatitis 2002;46:244
44. Le Coz CJ, Leclere JM, Arnoult E, et al. Allergic contact dermatitis from shellac in mascara. Contact Dermatitis 2002;146:149-52
45. Schwartz B, Harrison LH, Motter JS, et al. Investigation of an outbreak of Moraxella conjunctivitis at a Navajo boarding school. Am J Ophthalmol 1989;107:341-7
46. Al-Ashban RM, Aslam M, Shah AH. Kohl (surma): a toxic traditional eye cosmetic study in Saudi Arabia. Public Health 22004;118:292-8
47. Nir A, Tamir A, Zelnik N, Iancu TC. Is eye cosmetic a source of lead poisoning? Isr J Med Sci 1992;28:417-21
48. Cavanagh HD. Over the counter cosmetic colored contact lenses: deja vu (disaster!) all over again! Eye Contact Lens 2003;29:195
49. Stamler JF. The complications of contact lens wear. Curr Opin Ophthalmol 1998;9:66-71
50. Sendele DD, Kenyon KR, Mobilia EF, et al. Superior limbic keratoconjunctivitis in contact lens wearers. Ophthalmology 1983;90:616-22
51. Suchecki JK, Donshik P, Ehlers WH. Contact lens complications. Ophthalmol Clin North Am 2003;16:47l-84
52. Connell BJ, Tullo A, Morgan PB, Armstrong M. Pseudomonas aeruginosa microbial keratitis secondary to cosmetic coloured contact lens wear. Br J Ophthalmol 2004;88:1603-4
53. Johns KJ, O'Day DM. Pseudomonas corneal ulcer associated with colored cosmetic contact lenses in an emmetropic individual. Am J Ophthalmol 1988;105:210
54. Steinemann TL, Pinninti U, Szczotka LB, et al. Ocular complications associated with the use of cosmetic contact lenses from unlicensed vendors. Eye Contact Lens 2003;29:196-200
55. Kaiserman I. Severe allergic blepharoconjunctivitis induced by a dye for eyelashes and eyebrows. Ocul Immunol Inflamm 2003;11:149-51
56. Mselle J. The role of eyelash dyes in allergic eye diseases. Trop Doct 2004;34:235-6
57. FDA US Food and Drug Administration Center for Food Safety and Applied Nutrition. Office of Cosmetics and Colors Fact Sheet Nov 29 2000, updated July 1 2004. http://www.cfsan.fda.gov/-dms/cos-204.html., http://www.cfsan.fda.gov/-dms/cos-821.html
58. Gallardo MJ, Randleman JB, Price KM, et al. Ocular argyrosis after long-term self-application of eyelash tint. Am J Ophthalmol 2006;41:198-200
59. Lyon DB, Raphtis CS. Management of complications of blepharoplasty. Int Ophthalmol Clin 1997;37:205-16
60. Latkany R, Lock B, Speaker J. Nocturnal lagophthalmos: an overview and classification. Ocular Surface 2006;4:44-53
61. Patipa M. The evaluation and management of lower eyelid retraction following cosmetic surgery. Plast Reconstr Surg 2000;106:438-53; discussion 454-9
62. Ferri M, Oestreicher JH. Treatment of post-blepharoplasty lower lid retraction by free tarsoconjunctival grafting. Orbit 2002;21:281-8
63. Ghabrial R, Lisman RD, Kane MA, et al. Diplopia following transconjunctival blepharoplasty. Plast Reconstr Surg 1998;102:1219-25
64. Good CD, Cassidy LM, Moseley IF, Sanders MD. Posterior optic nerve infarction after lower lid blepharoplasty. J Neuro-Ophthalmol 1999;19:176-9
65. Hass AN, Penne RB, Stefanyszyn MA, Flanagan JC. Incidence of postblepharoplasty orbital haemorrhage and associated visual loss. Ophthal Plasti Reconstruct Surg 2004;20:426-32
66. Carter SR, Stewart JM, Khan J, et al. Infection after blepharoplasty with and without carbon dioxide laser resurfacing. Ophthalmology 2003;110:1430-2
67. Morgan SC. Orbital cellulitis and blindness following a blepharoplasty. Plast Reconstr Surg 1979;64:823-6
68. Goldberg RA, Li TG. Postoperative infection with group A betahemolytic Streptococcus after blepharoplasty. Am J Ophthalmol 2002;134:908-10
69. Suner IJ, Meldrum ML, Johnson TE, Tse DT. Necrotizing fasciitis after cosmetic blepharoplasty. Am J Ophthlamol 1999;128:367-8
70. Rohrich RJ, Gyimesi IM, Clark P, Burns AJ. CO2 laser safety considerations in facial skin resurfacing. Plast Reconstr Surg 1997;100:1285-90
71. Flynn TC. Periocular botulinum toxin Clin Dermatol 2003;21:498-504
72. Said S, Meshkinpour A, Carruthers A, Carruthers J. Botulinum toxin A: its expanding role in dermatology and esthetics. Am J Clin Dermatol 4:609-16
73. Northington ME, Huang CC. Dry eyes and superficial punctate keratitis: a complication of treatment of glabelar dynamic rhytides with botulinum exotoxin A. Dermatol Surg 2004; 30(12 Pt 2):1515-7
74. Matarasso SL. Decreased tear expression with an abnormal Schirmer's test following botulinum toxin type A for the treatment of lateral canthal rhytides. Dermatol Sing 2002;28:149-52
75. Francis IC, Coroneo MT. Botulinum toxin increases tearing in patients with Sjogren's syndrome: a preliminary report. J Rheumatol 1998;25:1859
76. Kalra HK, Magoon EH. Side effects of the use of botulinum toxin for the treatment of benign essential blepharospasm and hemifacial spasm. Ophthalmic Surg 1990;21:335-8
77. Frueh BR, Nelson CC, Kapustiak JF, Musch DC. The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment. Am J Ophthalmol 1988;106:45-7
78. Schaller UC, van der Velden EM, Drost BH, et al. [Keratography (corneal tattooing) in corneal leukoma]. Ophthalmologe 2001;98:147-50
79. Mannis MJ, Eghbali K, Schwab IR. Keratopicmentation: a review of corneal tattooing. Cornea 1999;18:633-7
80. Anastas CN, McGhee CN, Webber SK, Bryce IG. Corneal tattooing revisited: excimer laser in the treatment of unsightly leucomata. Aust N Z J Ophthalmol. 1995;23:227-30
81. Konuk O, Evereklioglu C, Hondur A, Unal M. Protective eye shield can prevent corneal trauma during micropigmentation for permanent cosmetic eyeliner. [Case Reports. Letter]. J Eur Acad Dermatol Venereol 2004;18:642-4
82. Kreidstein ML, Giguere D, Freiberg A. MRI interaction with tattoo pigments: case report, pathophysiology, and management. Plast Reconstruct Surg 1997;99:1717-20
83. Yang DS, Kim SC, Lee S, Chung Y. Foreign body epithelioid granuloma after cosmetic eyebrow tattooing. Cutis 1989;43:244-7
84. Schwarze HP, Giordano-Labadie F, Loche F, et al. Delayed-hyper-sensitivity granulomatous reaction induced by blepharopigmentation with aluminum-silicate. J Am Acad Dermatol 2000;42(5 Pt 2):888-91
85. Peters NT, Conn H, Cote MA. Extensive lower eyelid pigment spread after blepharopigmentation. Ophthal Plast Reconstr Surg 1999;15:445-7
86. Goldberg RA, Shorr N. Complications of blepharopigmentation. Ophthalmic Surg 1989;20:420-3
87. Lee IW, Ahn SK, Choi EH, et al. Complications of eyelash and eyebrow tattooing: reports of 2 cases of pigment fanning. Cutis 2001;68:53-5
88. Geronemus RG. Surgical pearl: Q-switched Nd:YAG laser removal of eyeliner tattoo. J Am Acad Dermatol 1996;35:101-2
89. Chiang JK, Barsky S, Bronson DM. Tretinoin in the removal of eyeliner tattoo. J Am Acad Dermatol 1999;40(6 Pt 1):999-1001
90. Moschos MM, Guex-Crosier Y. Retinal vasculitis and cystoid macular edema after body tattooing: a case report. Klin Monatsbl Augenheilkd 2004;221:424-6
91. Stirn A. Body piercing: medical consequences and psychological motivations. Lancet 2003; 361:1205-15
92. Horle S, Kuba GB. [Complications following eyebrow piercing]. Ophthalmologe 2002;99:200-2
93. Melles GR, Veners B, van der Linden JW: Cosmetic extraocular implant. J Cataract Refract Surg 2004;30:1595-6
94. Soparkar CN, Wilhelmus KR, Koch D, et al. Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants. Arch Ophthalmol 1997;115:34-8
95. Gordon DM. Ocular decongestants. Am J Ophthalmol 1959; 48:3956
96. Williams TL, Williams AJ, Enzenauer RW. Case report: unilateral mydriasis from topical Opcon-A and soft contact lens. Aviat Space Environ Med 1997;68:1035-7
97. Rumelt MB. Blindness from misuse of over-the-counter eye medications. Ann Ophthalmol 1988;20:26-30
98. Epstein DL, Boger WP III, Grant WM. Phenylephrine provocative testing in the pigmentary dispersion sydrome. Am J Ophthalmol 1979;97:286-7
99. Aronson SB, Yamamoto EA. Ocular hypersensitivity to epinephrine. Invest Ophthalmol 1966;5:75-80
100. Hanna C, Brainard J. Allergic dermatoconjunctivitis caused by phenylephrine. Am J Ophthalmol 1983;95:703-4
101. Herman DC, Bartley GB. Corneal opacities secondary to topical naphazoline and antazoline (Albalon-A). Am J Ophthalmol 1987;103:110-11
102. Martens PR. Pseudo neurological deterioration due to naphazoline eye ointment. Anaesth Intensive Care 1990;18:269
103. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Exp Eye Res 2001;72:331-9
104. Cook BE Jr, Holtan SB. Mydriasis from inadvertent topical application of naphazoline hydrochloride (Opcon-A, Bausch & Lomb). CLAO J 1998;24:72
105. Asbell PA. Potapova N. Effects of topical antiglaucoma medications on the ocular surface. Ocular Surface 2005;3:27-40
106. Johnstone MA, Albert DM. Prostaglandin-induced hair growth. Surv Ophthalmol 2002;47(Suppl 1):S185-S202
107. Reynolds A, Murray PI, Colloby PS. Darkening of eyelashes in a patient treated with latanoprost. Eye 1998;12 (Pt 4):741-3
108. Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997;124:544-7
109. Casson RJ, Selva D. Lash ptosis caused by latanoprost. Am J Ophthalmol 2005;139:932-3
110. Bearden W, Anderson R. Trichiasis associated with prostag-landin analog use. Ophthal Plast Reconstr Surg 2004;20:320-2
111. Chen CS, Wells J, Craig JE. Topical prostaglandin F(2alpha) analog induced poliosis. Am J Ophthalmol 2004;137:965-6
112. Woo TL, Francis IC. Intermittent blurred vision and trichomegaly due to latanoprost. Clin Exper Ophthalmol 2001;29:272-3
113. Teus MA, Arranz-Marquez E, Lucea-Suescun P. Incidence of iris colour change in latanoprost treated eyes. Br J Ophthalmol 2002;86:1085-8
114. Chiba T, Kashiwagi K, Chiba N, et al. Comparison of iridial pigmentation between latanoprost and isopropyl unoprostone: a long term prospective comparative study. Br J Ophthalmol 2003;87:956-9
115. Stjernschantz JW, Albert DM, Hu DN, et al. Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol 2002;47(Suppl 1):S162-S75
116. Grierson I, Jonsson M, Cracknell K. Latanoprost and pigmentation. Jpn J Ophthalmol 2004;48:602-12
117. Albert DM, Gangnon RE, Zimbric ML, et al. A study of iridectomy histopathologic features of latanoprost- and nonlatanoprost-treated patients. Arch Ophthalmol 2004;122:1680-5
118. Fraunfelder FT, Meyer SM, Menacker SJ. Alopecia possibly secondary to topical ophthalmic beta-blockers. JAMA 1990;263:1493-94
119. Roguedas AM, Misery L, Sassolas B, et al. Cutaneous manifestations of primary Sjogren's syndrome are underestimated. Clin Exp Rheumatol 2004;22:632-6
120. Mansberger SL, Cioffi GA. Eyelash formation secondary to latanoprost treatment in a patient with alopecia. Arch Ophthalmol 2000;118: 718-9
121. Mehta JS, Raman J, Gupta N, Thoung D. Cutaneous latanoprost in the treatment of alopecia areata. Eye 2003;17:444-6
122. Tully C. Deadly nightshade (Belladonna). http://www.shadowplayzine.com/Articles/belladonna.htm
123. Duncan G, Collison DJ. Role of the non-neuronal cholinergic system in the eye: a review. Life Sci 2003;72:2013-9
124. Rubinfeld RS, Currie JN. Accidental mydriasis From blue nightshade "lipstick." J Clin Neuro-ophthalmol 1987; 7:34-7